Researcher Profile Statistics: AMADO ISRAEL DE LA CRUZ GALINDO
Geo Map
Region
#
NA - North America
13
AS - Asia, other
8
EU - Europe
2
Total
23
Country
#
US - United States of America
12
CN - China
6
SG - Singapore
2
CA - Canada
1
FI - Finland
1
NL - Netherlands
1
Total
23
City
#
Louisville
8
Changi
2
Nanjing
2
Alameda
1
Fuzhou
1
Mountain View
1
Nanchang
1
Ningbo
1
San Diego
1
Tianjin
1
other
4
Total
23
Most viewed items
#
ID: 1219 - Adiponectin: Obesity and Development of Different Diseases
23
Total
23
Most type viewed
#
ID: other -
0
ID: journal -
23
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
23
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 1
1 0 0 1
0 1
4
2020
1 5
0 0 0 0
0 0 0 0
0 0
6
2022
0 0
0 0 0 0
0 0 0 0
3 1
4
2023
1 0
1 0 0 0
0 0 0 0
0 0
2
2024
1 1
2 0 0 0
0 0 0 0
0 0
4
Ever
23
Geo Map
Region | # |
---|---|
NA - North America | 13 |
AS - Asia, other | 8 |
EU - Europe | 2 |
Total | 23 |
Country | # |
---|---|
US - United States of America | 12 |
CN - China | 6 |
SG - Singapore | 2 |
CA - Canada | 1 |
FI - Finland | 1 |
NL - Netherlands | 1 |
Total | 23 |
City | # |
---|---|
Louisville | 8 |
Changi | 2 |
Nanjing | 2 |
Alameda | 1 |
Fuzhou | 1 |
Mountain View | 1 |
Nanchang | 1 |
Ningbo | 1 |
San Diego | 1 |
Tianjin | 1 |
other | 4 |
Total | 23 |
Most viewed items | # |
---|---|
ID: 1219 - Adiponectin: Obesity and Development of Different Diseases | 23 |
Total | 23 |
Most type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 23 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 23 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 4 |
2020 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 4 |
2023 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
2024 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
Ever | 23 |